Načítá se...
Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67
OBJECTIVE: Cancer immunoediting is the process of eliminating highly immunogenic tumor cells by somatic evolution and protecting the host from tumor development in the host immune system. Frequencies of somatic mutations or tumor mutation burden (TMB) were associated with immunogenicity of breast ca...
Uloženo v:
| Vydáno v: | Onco Targets Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5914885/ https://ncbi.nlm.nih.gov/pubmed/29719409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S159830 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|